19.07.2012 - Actelion raised its earnings outlook for 2012 on Thursday as cost cuts helped Europe's biggest biotech company to post a first-half profit despite its most important drug facing...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)